| Troy Flint Porter, MD | |
|
30 N 1900 E # 2b-200, Salt Lake City, UT 84132-0002 | |
| (801) 581-7092 | |
| Not Available |
| Full Name | Troy Flint Porter |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 38 Years |
| Location | 30 N 1900 E # 2b-200, Salt Lake City, Utah |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245310143 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207VM0101X | Obstetrics & Gynecology - Maternal & Fetal Medicine | 274397-1205 (Utah) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Intermountain Healthcare Services, Inc | 1850209420 | 3063 |
News Archive
In 2007, she became speaker -; and the first Californian to head the House -; overseeing passage of the most far-reaching healthcare overhaul since the creation of Medicare, an economic stimulus program, and the revamping of financial regulations, often with little or no Republican support. But while she -; and her Democratic majority -; ruled the House, she became a favorite Republican campaign target as evidence of what's wrong with Washington.
Families with special needs kids can save up to a third of their out-of pocket medical expenses by having a so-called "medical home" coordinate the care for their child, a news study suggests. A medical home could be a primary care doctor's office that incorporates the family in medical decision-making and coordinates and follows up on visits to specialists.
Checkpoint inhibitors, a type of immunotherapy, that target myeloid immune cells and slow tumor growth were discovered by a team from the Perelman School of Medicine at the University of Pennsylvania and other institutions.
Osteopore International Pte Ltd, a Singapore-headquartered company leading the way in regenerative bone implants, is proud to announce the success of its technology in a new medical procedure that took place in Brisbane, Australia, in December last year.
Micromet, Inc. today announced that it has initiated a phase 2 trial of its lead product candidate blinatumomab (MT103) in adult patients with relapsed or refractory (r/r) B-precursor acute lymphoblastic leukemia (ALL). Blinatumomab is the first of a new class of agents called BiTE® antibodies, designed to harness the body's T cells to kill cancer cells.
› Verified 6 days ago
| Entity Name | Ihc Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629260880 PECOS PAC ID: 1850209420 Enrollment ID: O20031105000079 |
News Archive
In 2007, she became speaker -; and the first Californian to head the House -; overseeing passage of the most far-reaching healthcare overhaul since the creation of Medicare, an economic stimulus program, and the revamping of financial regulations, often with little or no Republican support. But while she -; and her Democratic majority -; ruled the House, she became a favorite Republican campaign target as evidence of what's wrong with Washington.
Families with special needs kids can save up to a third of their out-of pocket medical expenses by having a so-called "medical home" coordinate the care for their child, a news study suggests. A medical home could be a primary care doctor's office that incorporates the family in medical decision-making and coordinates and follows up on visits to specialists.
Checkpoint inhibitors, a type of immunotherapy, that target myeloid immune cells and slow tumor growth were discovered by a team from the Perelman School of Medicine at the University of Pennsylvania and other institutions.
Osteopore International Pte Ltd, a Singapore-headquartered company leading the way in regenerative bone implants, is proud to announce the success of its technology in a new medical procedure that took place in Brisbane, Australia, in December last year.
Micromet, Inc. today announced that it has initiated a phase 2 trial of its lead product candidate blinatumomab (MT103) in adult patients with relapsed or refractory (r/r) B-precursor acute lymphoblastic leukemia (ALL). Blinatumomab is the first of a new class of agents called BiTE® antibodies, designed to harness the body's T cells to kill cancer cells.
› Verified 6 days ago
| Entity Name | Ihc Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942325154 PECOS PAC ID: 1850209420 Enrollment ID: O20080610000303 |
News Archive
In 2007, she became speaker -; and the first Californian to head the House -; overseeing passage of the most far-reaching healthcare overhaul since the creation of Medicare, an economic stimulus program, and the revamping of financial regulations, often with little or no Republican support. But while she -; and her Democratic majority -; ruled the House, she became a favorite Republican campaign target as evidence of what's wrong with Washington.
Families with special needs kids can save up to a third of their out-of pocket medical expenses by having a so-called "medical home" coordinate the care for their child, a news study suggests. A medical home could be a primary care doctor's office that incorporates the family in medical decision-making and coordinates and follows up on visits to specialists.
Checkpoint inhibitors, a type of immunotherapy, that target myeloid immune cells and slow tumor growth were discovered by a team from the Perelman School of Medicine at the University of Pennsylvania and other institutions.
Osteopore International Pte Ltd, a Singapore-headquartered company leading the way in regenerative bone implants, is proud to announce the success of its technology in a new medical procedure that took place in Brisbane, Australia, in December last year.
Micromet, Inc. today announced that it has initiated a phase 2 trial of its lead product candidate blinatumomab (MT103) in adult patients with relapsed or refractory (r/r) B-precursor acute lymphoblastic leukemia (ALL). Blinatumomab is the first of a new class of agents called BiTE® antibodies, designed to harness the body's T cells to kill cancer cells.
› Verified 6 days ago
| Entity Name | University Of Utah Specialty Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043614811 PECOS PAC ID: 2961726831 Enrollment ID: O20150123002141 |
News Archive
In 2007, she became speaker -; and the first Californian to head the House -; overseeing passage of the most far-reaching healthcare overhaul since the creation of Medicare, an economic stimulus program, and the revamping of financial regulations, often with little or no Republican support. But while she -; and her Democratic majority -; ruled the House, she became a favorite Republican campaign target as evidence of what's wrong with Washington.
Families with special needs kids can save up to a third of their out-of pocket medical expenses by having a so-called "medical home" coordinate the care for their child, a news study suggests. A medical home could be a primary care doctor's office that incorporates the family in medical decision-making and coordinates and follows up on visits to specialists.
Checkpoint inhibitors, a type of immunotherapy, that target myeloid immune cells and slow tumor growth were discovered by a team from the Perelman School of Medicine at the University of Pennsylvania and other institutions.
Osteopore International Pte Ltd, a Singapore-headquartered company leading the way in regenerative bone implants, is proud to announce the success of its technology in a new medical procedure that took place in Brisbane, Australia, in December last year.
Micromet, Inc. today announced that it has initiated a phase 2 trial of its lead product candidate blinatumomab (MT103) in adult patients with relapsed or refractory (r/r) B-precursor acute lymphoblastic leukemia (ALL). Blinatumomab is the first of a new class of agents called BiTE® antibodies, designed to harness the body's T cells to kill cancer cells.
› Verified 6 days ago
| Entity Name | University Of Utah Adult Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114321981 PECOS PAC ID: 0941525273 Enrollment ID: O20150209001683 |
News Archive
In 2007, she became speaker -; and the first Californian to head the House -; overseeing passage of the most far-reaching healthcare overhaul since the creation of Medicare, an economic stimulus program, and the revamping of financial regulations, often with little or no Republican support. But while she -; and her Democratic majority -; ruled the House, she became a favorite Republican campaign target as evidence of what's wrong with Washington.
Families with special needs kids can save up to a third of their out-of pocket medical expenses by having a so-called "medical home" coordinate the care for their child, a news study suggests. A medical home could be a primary care doctor's office that incorporates the family in medical decision-making and coordinates and follows up on visits to specialists.
Checkpoint inhibitors, a type of immunotherapy, that target myeloid immune cells and slow tumor growth were discovered by a team from the Perelman School of Medicine at the University of Pennsylvania and other institutions.
Osteopore International Pte Ltd, a Singapore-headquartered company leading the way in regenerative bone implants, is proud to announce the success of its technology in a new medical procedure that took place in Brisbane, Australia, in December last year.
Micromet, Inc. today announced that it has initiated a phase 2 trial of its lead product candidate blinatumomab (MT103) in adult patients with relapsed or refractory (r/r) B-precursor acute lymphoblastic leukemia (ALL). Blinatumomab is the first of a new class of agents called BiTE® antibodies, designed to harness the body's T cells to kill cancer cells.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Troy Flint Porter, MD Po Box 5889, Salt Lake City, UT 84158-0859 Ph: (801) 585-5172 | Troy Flint Porter, MD 30 N 1900 E # 2b-200, Salt Lake City, UT 84132-0002 Ph: (801) 581-7092 |
News Archive
In 2007, she became speaker -; and the first Californian to head the House -; overseeing passage of the most far-reaching healthcare overhaul since the creation of Medicare, an economic stimulus program, and the revamping of financial regulations, often with little or no Republican support. But while she -; and her Democratic majority -; ruled the House, she became a favorite Republican campaign target as evidence of what's wrong with Washington.
Families with special needs kids can save up to a third of their out-of pocket medical expenses by having a so-called "medical home" coordinate the care for their child, a news study suggests. A medical home could be a primary care doctor's office that incorporates the family in medical decision-making and coordinates and follows up on visits to specialists.
Checkpoint inhibitors, a type of immunotherapy, that target myeloid immune cells and slow tumor growth were discovered by a team from the Perelman School of Medicine at the University of Pennsylvania and other institutions.
Osteopore International Pte Ltd, a Singapore-headquartered company leading the way in regenerative bone implants, is proud to announce the success of its technology in a new medical procedure that took place in Brisbane, Australia, in December last year.
Micromet, Inc. today announced that it has initiated a phase 2 trial of its lead product candidate blinatumomab (MT103) in adult patients with relapsed or refractory (r/r) B-precursor acute lymphoblastic leukemia (ALL). Blinatumomab is the first of a new class of agents called BiTE® antibodies, designed to harness the body's T cells to kill cancer cells.
› Verified 6 days ago
Virginia Jean Homewood, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3336 S 4155 W, Ste 301, Salt Lake City, UT 84120 Phone: 801-964-3865 Fax: 801-964-3894 | |
Alexandra L. Woodcock, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 30 N 1900 E Rm 2a200, Salt Lake City, UT 84132 Phone: 801-213-3716 | |
Lillian B. Boettcher, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 30 N 1900 E Rm 2b200, Salt Lake City, UT 84132 Phone: 801-581-7647 | |
Patricia Bearnson, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 4465 S 900 E Ste 275, Salt Lake City, UT 84124 Phone: 801-272-6100 Fax: 801-272-6101 | |
Eric C Nielson, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1220 East 3900 South, Suite 3e, Salt Lake City, UT 84124 Phone: 801-685-7188 Fax: 801-685-8116 | |
Susan T Horvath, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1140 E 3900 S Ste 400, Salt Lake City, UT 84124 Phone: 801-262-8666 Fax: 801-263-8821 | |
Carolyn Weaver Swenson, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 50 N Medical Dr, Salt Lake City, UT 84132 Phone: 801-213-2995 |